Latest News
All Times Eastern
- My wife wants us to spend $5,000 to attend her cousin’s destination wedding. I don’t want to go. Am I being selfish?
- ‘I feel used’: My partner stays with me 5 nights a week, even though he owns his own home. Should he pay for utilities and food?
- DeSantis promises to make America Florida. But Florida isn’t Florida anymore, critics say.
- Special counsel Durham to testify before House committee on June 20 about his investigate-the-investigators report
- From solemn reflection to ‘three-day hootenanny’: the evolution, and degradation, of the Memorial Day holiday
- How much does a mammogram cost? That depends on whether it’s ‘diagnostic’ or ‘screening.’
- How Joe Biden and Kevin McCarthy got to yes on their debt-ceiling compromise
- Global stock markets breathe a sigh of relief over Biden-McCarthy pact to avert U.S. debt default
- ‘He’s content living paycheck to paycheck’: My husband won’t work or get a driver’s license. Now things have gotten even worse.
- Don’t get stung by buy-now- pay-later services: ‘It is kind of a recipe for disaster if not managed carefully’
to be replaced
Bristol Myers Squibb Co.
BMYUS
$
0.26
0.05%
After Hours
$
63.85
After Hours Volume:
629.49K
| Close | Chg | Chg % |
|---|---|---|
| $63.82 | -0.74 | -1.15% |
Volume: 8.46M
65 Day Avg: 7.92M
63.70
Day Range
64.97
63.70
52 Week Range
81.44
Partner Center
Your Watchlists
Recently Viewed Tickers
Overview
BMY Overview
Key Data
- Open $64.51
- Day Range 63.70 - 64.97
- 52 Week Range 63.70 - 81.44
- Market Cap $134.08B
- Shares Outstanding 2.1B
- Public Float 2.1B
- Beta 0.54
- Rev. per Employee $1.337M
- P/E Ratio 18.60
- EPS $3.43
- Yield 3.57%
- Dividend $0.57
- Ex-Dividend Date Apr 6, 2023
- Short Interest 21.49M 05/15/23
- % of Float Shorted 1.02%
- Average Volume 7.92M
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings 24
Full Ratings
Recent News
Biotech and Pharma NASH Drugs Suffer Another Blow, but Hope Remains
Biotech and Pharma Biopharma Deals Are Hot. There’s More to Come—and These Stocks Can Benefit.
Biotech and Pharma Healthcare Is Back. But Is It Here to Stay?
10 Health Care Stocks Whale Activity In Today's Session
on Benzinga.com
Bristol-Myers Squibb Unusual Options Activity
on Benzinga.com
Quant Ratings Updated on 119 Stocks
on InvestorPlace.com
10 Health Care Stocks Whale Activity In Today's Session
on Benzinga.com
BMO Capital Keeps Their Buy Rating on Bristol Myers (BMY)
on TipRanks.com
Goldman Sachs Sticks to Their Buy Rating for Bristol Myers (BMY)
on TipRanks.com
10 Health Care Stocks Whale Activity In Today's Session
on Benzinga.com
1 Dirt Cheap Dividend Stock to Buy in May
on Motley Fool
Dr. Reddy's Laboratories (RDY) Is the Pharmaceutical Stock to Buy
on StockNews.com
Looking Into Bristol-Myers Squibb's Recent Short Interest
on Benzinga.com
Is Bristol-Myers Squibb Stock a Buy Now?
on Motley Fool
3 High-Yielding Dividend Stocks That Could Pay You Forever
on Motley Fool
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.
Competitors
| Name | Chg % | Market Cap |
|---|---|---|
| Johnson & Johnson | $401.11B | |
| Pfizer Inc. | $212.26B | |
| Abbott Laboratories | $178.89B | |
| AbbVie Inc. | $242.7B | |
| Merck & Co. Inc. | $281.83B | |
| Novartis AG | CHF176.07B | |
| AstraZeneca PLC ADR | $225.23B | |
| AstraZeneca PLC | £182.64B | |
| Sanofi S.A. | €124.64B | |
| GSK PLC | £56.68B |